Mycosis fungoides and Sézary syndrome
Open Access
- 19 February 2026
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 208 (4) , 1207-1210
Abstract
Summary: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T‐cell lymphomas, arising from mature CD4 + memory T cells. Diagnosis is complex and relies on clinicopathological correlation, immunophenotyping and molecular clonality testing, while management is stage‐adapted, with potentially curative outcomes achievable only in selected patients through allogeneic haematopoietic stem cell transplantation.Keywords
This publication has 13 references indexed in Scilit:
- A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratificationBlood, 2025
- Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implicationsBritish Journal of Dermatology, 2024
- Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2022
- Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018JAMA Oncology, 2022
- Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCBlood, 2022
- Genetic and epigenetic insights into cutaneous T-cell lymphomaBlood, 2022
- Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 PatientsCancers, 2020
- Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-AnalysisJournal of Investigative Dermatology, 2020
- Early-stage Mycosis Fungoides: Epidemiology and PrognosisActa Dermato-Venereologica, 2020
- Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009Clinical Cancer Research, 2012